Clinical Application of Bioprosthesis in China: Current Status and Future
Clinical Application of Bioprosthesis in China: Current Status and Future
复制标题
中国生物假体的临床应用：现状与未来
DOI：
10.1007/s11596-019-2068-5
复制
发表时间：
2019-08-01
影响因子：
2.4
通讯作者：
Dong, Nian-guo
中科院分区：
文献类型：
--
作者：
Wang, Yin;Jiang, Wei-wei;Dong, Nian-guo
我国是心脏瓣膜病发病率较高的国家之一，但由于患者多为年轻的风湿性心脏病患者，生物瓣膜在我国的使用受到限制。该生物瓣在我国具有良好的应用前景。一方面，新一代生物瓣膜在抗钙化处理、抗代谢、材料质量控制、瓣架力学设计、瓣叶缝合技术等方面有了显著提升，应用效果提升;另一方面，外科医生要适应新的观念变化，正确认识和合理应用生物瓣，主瓣修复，房颤消融等技术，结合介入、微创等技术，根据病情的具体情况选择手术方式，保证患者的长期生活质量。
China is one of the countries which have a high incidence of heart valvular disease, but the use of biological valve is limited in China before because the majority of patients are young patients suffering from rheumatic heart disease. The biological valve has a good application prospect in China. On the one hand, the new generation of biological valves have been significantly improved in the aspects of anti-calcification treatment, anti-metabolism, material quality control, valve frame mechanics design, and leaflet sewing technology, and the application effect is improved; on the other hand, surgeons should adapt to the new concept changes, and correctly understand and rationally apply biological valves, master valve repair, atrial fibrillation ablation and other techniques, combined with interventional, minimally invasive techniques, etc., according to the specific conditions of the disease and choose the surgery type to ensure the patients’ long-term life quality.